Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder

Takuji Uemura, Marty Green, Timothy Corson, Tatiana Perova, Peter P. Li, Jerry J. Warsh

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objectives: Disrupted intracellular calcium (Ca2+) homeostasis (ICH) related to mitochondrial and/or endoplasmic reticulum (ER) dysfunction has been implicated in bipolar disorder (BD). The anti-apoptotic protein B-cell CLL/lymphoma 2 (Bcl-2), encoded in a putative BD susceptibility locus, modulates ER-Ca2+ dynamics. Recently, an intronic single-nucleotide polymorphism (SNP) in the Bcl-2 gene, rs956572, was suggested as a functionally active SNP that influences its messenger RNA (mRNA) and protein level as well as human gray matter volume. We sought to evaluate the impact of this variant on ICH in BD. Methods: Basal intracellular Ca2+ concentrations ([Ca2+]B) and rs956572 genotypes were determined in B lymphoblast cell lines (BLCLs) from bipolar I disorder (BD-I) (n=150), bipolar II disorder (BD-II) (n=65), and major depressive disorder (n=30) patients, and from healthy subjects (n=70). Bcl-2 mRNA and protein levels were determined by quantitative reverse transcriptase polymerase chain reaction and immunoblotting, respectively. Functional interactions of rs956572 with ICH were assessed by thapsigargin- and lysophosphatidic acid (LPA)-stimulated Ca2+ responses. Results: Although rs956572 variation was not significantly associated with BD, BD-I, or BD-II, BLCL [Ca2+]B was significantly higher in BD-I G/G patients compared with other genotypes and with healthy subjects. Bcl-2 mRNA and protein levels were lowest in BD-I G/G patients. Compared with A carriers, BD-I patients with G/G variants showed a modest enhancing effect on thapsigargin- and LPA-stimulated Ca2+ responses. Conclusions: These findings support the notion that genetic variation in Bcl-2 affecting its expression impacts ICH in BD. Moreover, we show here for the first time that this interactive effect is diagnostically specific to BD-I.

Original languageEnglish (US)
Pages (from-to)41-51
Number of pages11
JournalBipolar Disorders
Volume13
Issue number1
DOIs
StatePublished - Feb 2011
Externally publishedYes

Fingerprint

B-Cell Lymphoma
Bipolar Disorder
Single Nucleotide Polymorphism
Homeostasis
Calcium
Thapsigargin
Endoplasmic Reticulum
Messenger RNA
Healthy Volunteers
Genotype
Cell Line
Apoptosis Regulatory Proteins
Proteins
Major Depressive Disorder
Reverse Transcriptase Polymerase Chain Reaction
Immunoblotting

Keywords

  • B lymphoblast cell lines
  • Bcl-2
  • Bipolar disorder
  • Endoplasmic reticulum
  • Intracellular calcium homeostasis
  • SNP

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder. / Uemura, Takuji; Green, Marty; Corson, Timothy; Perova, Tatiana; Li, Peter P.; Warsh, Jerry J.

In: Bipolar Disorders, Vol. 13, No. 1, 02.2011, p. 41-51.

Research output: Contribution to journalArticle

Uemura, Takuji ; Green, Marty ; Corson, Timothy ; Perova, Tatiana ; Li, Peter P. ; Warsh, Jerry J. / Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder. In: Bipolar Disorders. 2011 ; Vol. 13, No. 1. pp. 41-51.
@article{3eac53b9b0164c868ffbe6a62fa0563d,
title = "Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder",
abstract = "Objectives: Disrupted intracellular calcium (Ca2+) homeostasis (ICH) related to mitochondrial and/or endoplasmic reticulum (ER) dysfunction has been implicated in bipolar disorder (BD). The anti-apoptotic protein B-cell CLL/lymphoma 2 (Bcl-2), encoded in a putative BD susceptibility locus, modulates ER-Ca2+ dynamics. Recently, an intronic single-nucleotide polymorphism (SNP) in the Bcl-2 gene, rs956572, was suggested as a functionally active SNP that influences its messenger RNA (mRNA) and protein level as well as human gray matter volume. We sought to evaluate the impact of this variant on ICH in BD. Methods: Basal intracellular Ca2+ concentrations ([Ca2+]B) and rs956572 genotypes were determined in B lymphoblast cell lines (BLCLs) from bipolar I disorder (BD-I) (n=150), bipolar II disorder (BD-II) (n=65), and major depressive disorder (n=30) patients, and from healthy subjects (n=70). Bcl-2 mRNA and protein levels were determined by quantitative reverse transcriptase polymerase chain reaction and immunoblotting, respectively. Functional interactions of rs956572 with ICH were assessed by thapsigargin- and lysophosphatidic acid (LPA)-stimulated Ca2+ responses. Results: Although rs956572 variation was not significantly associated with BD, BD-I, or BD-II, BLCL [Ca2+]B was significantly higher in BD-I G/G patients compared with other genotypes and with healthy subjects. Bcl-2 mRNA and protein levels were lowest in BD-I G/G patients. Compared with A carriers, BD-I patients with G/G variants showed a modest enhancing effect on thapsigargin- and LPA-stimulated Ca2+ responses. Conclusions: These findings support the notion that genetic variation in Bcl-2 affecting its expression impacts ICH in BD. Moreover, we show here for the first time that this interactive effect is diagnostically specific to BD-I.",
keywords = "B lymphoblast cell lines, Bcl-2, Bipolar disorder, Endoplasmic reticulum, Intracellular calcium homeostasis, SNP",
author = "Takuji Uemura and Marty Green and Timothy Corson and Tatiana Perova and Li, {Peter P.} and Warsh, {Jerry J.}",
year = "2011",
month = "2",
doi = "10.1111/j.1399-5618.2011.00897.x",
language = "English (US)",
volume = "13",
pages = "41--51",
journal = "Bipolar Disorders",
issn = "1398-5647",
publisher = "Blackwell Munksgaard",
number = "1",

}

TY - JOUR

T1 - Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder

AU - Uemura, Takuji

AU - Green, Marty

AU - Corson, Timothy

AU - Perova, Tatiana

AU - Li, Peter P.

AU - Warsh, Jerry J.

PY - 2011/2

Y1 - 2011/2

N2 - Objectives: Disrupted intracellular calcium (Ca2+) homeostasis (ICH) related to mitochondrial and/or endoplasmic reticulum (ER) dysfunction has been implicated in bipolar disorder (BD). The anti-apoptotic protein B-cell CLL/lymphoma 2 (Bcl-2), encoded in a putative BD susceptibility locus, modulates ER-Ca2+ dynamics. Recently, an intronic single-nucleotide polymorphism (SNP) in the Bcl-2 gene, rs956572, was suggested as a functionally active SNP that influences its messenger RNA (mRNA) and protein level as well as human gray matter volume. We sought to evaluate the impact of this variant on ICH in BD. Methods: Basal intracellular Ca2+ concentrations ([Ca2+]B) and rs956572 genotypes were determined in B lymphoblast cell lines (BLCLs) from bipolar I disorder (BD-I) (n=150), bipolar II disorder (BD-II) (n=65), and major depressive disorder (n=30) patients, and from healthy subjects (n=70). Bcl-2 mRNA and protein levels were determined by quantitative reverse transcriptase polymerase chain reaction and immunoblotting, respectively. Functional interactions of rs956572 with ICH were assessed by thapsigargin- and lysophosphatidic acid (LPA)-stimulated Ca2+ responses. Results: Although rs956572 variation was not significantly associated with BD, BD-I, or BD-II, BLCL [Ca2+]B was significantly higher in BD-I G/G patients compared with other genotypes and with healthy subjects. Bcl-2 mRNA and protein levels were lowest in BD-I G/G patients. Compared with A carriers, BD-I patients with G/G variants showed a modest enhancing effect on thapsigargin- and LPA-stimulated Ca2+ responses. Conclusions: These findings support the notion that genetic variation in Bcl-2 affecting its expression impacts ICH in BD. Moreover, we show here for the first time that this interactive effect is diagnostically specific to BD-I.

AB - Objectives: Disrupted intracellular calcium (Ca2+) homeostasis (ICH) related to mitochondrial and/or endoplasmic reticulum (ER) dysfunction has been implicated in bipolar disorder (BD). The anti-apoptotic protein B-cell CLL/lymphoma 2 (Bcl-2), encoded in a putative BD susceptibility locus, modulates ER-Ca2+ dynamics. Recently, an intronic single-nucleotide polymorphism (SNP) in the Bcl-2 gene, rs956572, was suggested as a functionally active SNP that influences its messenger RNA (mRNA) and protein level as well as human gray matter volume. We sought to evaluate the impact of this variant on ICH in BD. Methods: Basal intracellular Ca2+ concentrations ([Ca2+]B) and rs956572 genotypes were determined in B lymphoblast cell lines (BLCLs) from bipolar I disorder (BD-I) (n=150), bipolar II disorder (BD-II) (n=65), and major depressive disorder (n=30) patients, and from healthy subjects (n=70). Bcl-2 mRNA and protein levels were determined by quantitative reverse transcriptase polymerase chain reaction and immunoblotting, respectively. Functional interactions of rs956572 with ICH were assessed by thapsigargin- and lysophosphatidic acid (LPA)-stimulated Ca2+ responses. Results: Although rs956572 variation was not significantly associated with BD, BD-I, or BD-II, BLCL [Ca2+]B was significantly higher in BD-I G/G patients compared with other genotypes and with healthy subjects. Bcl-2 mRNA and protein levels were lowest in BD-I G/G patients. Compared with A carriers, BD-I patients with G/G variants showed a modest enhancing effect on thapsigargin- and LPA-stimulated Ca2+ responses. Conclusions: These findings support the notion that genetic variation in Bcl-2 affecting its expression impacts ICH in BD. Moreover, we show here for the first time that this interactive effect is diagnostically specific to BD-I.

KW - B lymphoblast cell lines

KW - Bcl-2

KW - Bipolar disorder

KW - Endoplasmic reticulum

KW - Intracellular calcium homeostasis

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=79951498943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951498943&partnerID=8YFLogxK

U2 - 10.1111/j.1399-5618.2011.00897.x

DO - 10.1111/j.1399-5618.2011.00897.x

M3 - Article

C2 - 21320251

AN - SCOPUS:79951498943

VL - 13

SP - 41

EP - 51

JO - Bipolar Disorders

JF - Bipolar Disorders

SN - 1398-5647

IS - 1

ER -